Key Statistics
Market Cap$42.29B
P/E Ratio136.8
Div. Yield—
EPS (TTM)$2.33
52W High$495.55
52W Low$205.87
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees2,500
Price Performance
1 Week+0.47%
3 Month-19.85%
1 Year+21.62%
FinancialsAnnual · QuiverQuant
Revenue$1.83B
Assets$3.83B
Liabilities$4.05B
Net Income$440.24M loss
About
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ALNY with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.